The Harm Reduction Argument for Legalizing Kidney Markets

ResearchSpace Repository

Show simple item record Wilkinson, Timothy en Wilkinson, M en
dc.contributor.editor Sturma, D en
dc.contributor.editor Heinrichs, B en
dc.contributor.editor Honnefelder, L en 2020-01-08T02:24:56Z en 2018-05 en
dc.identifier.citation Jahrbuch für Wissenschaft und Ethik 23(1):109-124 May 2018 en
dc.identifier.issn 1430-9017 en
dc.identifier.uri en
dc.description.abstract In the illegal kidney trade, sellers are often ripped off, coerced, not given proper medical care, and misled about the dangers and illegality of nephrectomy. Recipients often pay for poor quality surgery and unhealthy or mismatched kidneys. Some writers argue that the illegality is what causes these harms and wrongs, not the trade in itself. They say the legalization of kidney sales would reduce harm. This harm reduction claim is what I develop and assess in this article. The article sets out the ethical and empirical components of a utilitarian version of harm reduction. It explains how legalization would probably reduce the harms of black markets but why we do not know how legalization would affect the supply of organs or the number of harmful transactions in a white market. In short, we cannot be confident that legalization would reduce harm overall. However, I try to show how the case for legalization might be strengthened by adding to the utilitarian focus on aggregate welfare. A special concern for the worst off and a concern to avoid the wrongs of sale both turn out to be likely better met by legalization than criminalization. The harm reduction argument does not settle the debate about legalizing the organ trade but it has more force than critics of sale have realized. en
dc.publisher De Gruyter en
dc.relation.ispartofseries Jahrbuch für Wissenschaft und Ethik en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri en
dc.rights.uri en
dc.title The Harm Reduction Argument for Legalizing Kidney Markets en
dc.type Journal Article en
dc.identifier.doi 10.1515/jwiet-2018-230108 en
pubs.issue 1 en
pubs.begin-page 109 en
pubs.volume 23 en
dc.rights.holder Copyright: Walter de Gruyter GmbH en
pubs.end-page 124 en
dc.rights.accessrights en
pubs.subtype Article en
pubs.elements-id 789111 en Arts en Social Sciences en Politics & International Relations en
dc.identifier.eissn 1613-1142 en
pubs.record-created-at-source-date 2019-12-16 en 2019-04-05 en

Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace

Advanced Search